Atlas Trials

Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome

Clinical trial NCT04179383 · UNKNOWN

Trial details

NCT number
NCT04179383
Sponsor
University Hospital, Montpellier
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Reversible Cerebral Vasoconstriction Syndrome
Start date
2019-12-05
Primary completion
2024-06-01
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.